GuangzhouJune 15, 2026 /PRNewswire/ — On June 12, 2026, the “Strategic Upgrade of the Chinese Herbal Medicine + Probiotics Collaborative Innovation Research Center and Chinese Body Shape Management Achievement Release Conference” was grandly held in Guangzhou. Infinitus (China) Co., Ltd. and Jiangnan University formally signed a new phase of strategic cooperation agreement and simultaneously released the latest achievements in Chinese body shape management, marking a deeper stage of collaborative innovation in the university-enterprise partnership.
Distinguished guests attending the event and witnessing this important moment included: Mr. Chen Wei, Academician of the Chinese Academy of Engineering, Director of the National Key Laboratory of Food Science and Resource Mining, and President of the China Nutrition and Health Food Association; Mr. Zhao Jianxin, Director of the Personnel Department of Jiangnan University, Professor at the School of Food Science and Technology, and Director of the International Science and Technology Cooperation Base for Probiotics and Gut Health; Mr. Cui Shumao, Professor at the School of Food Science and Technology, Jiangnan University, and Executive Dean of the Wuxi Special Food and Nutrition Health Research Institute; Mr. Wang Gang, Professor at the School of Food Science and Technology and Head of the Department of Food Nutrition and Health, Jiangnan University; Mr. Yu Jianglin, Global CEO of Infinitus and Vice Chairman of Infinitus (China) Co., Ltd.; and Mr. Ma Jun, Vice President and Chief Science and Technology Officer of Infinitus (China) Co., Ltd.
A Decade of Deep Cultivation Builds Trust, Partners Embark on a New Journey
Mr. Yu Jianglin delivers a speech
Mr. Yu Jianglin delivered a welcome speech on behalf of Infinitus, stating: “Trust is a new quality productive force that drives innovation and reduces collaboration costs. The long-term cooperation with a top-tier institution like Jiangnan University is a vivid practice of building ‘trust productivity.’ Over nearly a decade of partnership, every accumulation of experimental data and every implementation of scientific research results has added depth to this trust, ultimately solidifying into consumer confidence in Chinese herbal medicine health products.”
Academician Chen Wei delivers a speech
Academician Chen Wei reviewed the history of cooperation between the two parties, highly praised the achievements made so far, and pointed out: “In 2026, the cooperation between the two sides will undergo a comprehensive strategic upgrade, with the scope of collaboration further expanded and deepened. We will introduce cutting-edge technologies such as probiotic multi-omics and AI-predicted Chinese herbal medicine fermentation, focusing on in-depth research and development in the direction of postbiotics from fermented Chinese herbal medicines with probiotics. Additionally, leveraging the industrial transformation platform of the Wuxi Special Food Research Institute, we will vigorously promote the efficient implementation and industrial transformation of scientific research achievements.”
Signing Ceremony: Strategic Upgrade Sets Sail Again
Signing ceremony
Witnessed by all guests, Professor Zhao Jianxin and Mr. Ma Jun, as representatives of both parties, jointly signed the new phase strategic cooperation agreement, marking the entry of the industry-university-research collaboration into a deeper stage of synergistic innovation.
Academic Insights: Exploring the Frontier Trends of Chinese Herbal Medicine + Probiotics
Academician Chen Wei delivers a keynote speech
Academician Chen Wei delivered a speech titled “Exploration of Probiotic Biodiversity and Functional Analysis.” He pointed out that probiotic research has moved beyond traditional functions of immune regulation, metabolic regulation, and gut health to uncover more refined and precise physiological functions. Thanks to advancements in microbiological technologies such as culturomics, cell-level sorting, and AI sorting, the precision and efficiency of probiotic selection have been significantly improved. At the same time, from the perspective of the gut microbiome, the research team has clarified the remote physiological regulatory mechanisms of probiotics.
Professor Cui Shumao delivers a keynote speech
Professor Cui Shumao shared a keynote speech titled “Probiotics Assist in the Release and Efficacy of Active Molecules from Chinese Herbal Medicine (Medicine and Food Homology).” He noted that the gut microbiota is a key factor influencing the efficacy of Chinese herbal medicines, and probiotics can convert these herbs into highly active products. He also shared how cutting-edge technologies and AI empowerment can accelerate research and product industrialization. He specifically mentioned that the Lactobacillus reuteri strain CCFM8631, jointly developed by Infinitus and Jiangnan University, has been successfully applied to product upgrades, marking a transition from laboratory research to results that truly serve consumers.
Results Released: Chinese Body Shape Management Solution Unveiled
Mr. Zhou Yong shares platform achievements
Mr. Zhou Yong, Senior Manager of Frontier Technology Research at Infinitus, shared on behalf of both parties the scientific research achievements of the “Infinitus-Jiangnan University Chinese Herbal Medicine + Probiotics Collaborative Innovation Research Center.” The platform-supported Yang Gu Jian Chang Qing Ying probiotic solid beverage was successfully launched in 2024, and the Yang Gu Jian Xing Mei probiotic solid beverage has also been upgraded. Additionally, the platform has developed fermented raw materials such as licorice and ginseng. In terms of ongoing research, the team is advancing the development of various innovative fermented ingredients, including beauty-related complex polysaccharides like fermented Snow Lotus (Saussurea involucrata) and Dendrobium officinale, as well as probiotics for women’s intimate care and oral health.
Ms. Tao Qian shares the Chinese body shape management solution
Ms. Tao Qian, a health food researcher at Infinitus, released the Chinese body shape management solution on behalf of the company. She pointed out that national health demands are continuously evolving, from weight loss to muscle gain, and from weight management to body shape management, which has become a consensus across the population. She highlighted the Chinese body shape management philosophy: focusing on strengthening the spleen (a core concept in Traditional Chinese Medicine), integrating Chinese herbal medicine technology with modern nutrition, and incorporating a “Four Balances” lifestyle. This approach intervenes synergistically from three dimensions—regulating body constitution, optimizing intake, and promoting metabolism—to provide systematic and actionable health solutions for the Chinese people. She also shared that the proprietary strain CCFM8631, jointly developed by Infinitus and Jiangnan University, has been successfully industrialized and secured patent protection in both China and the United States. Based on the design concept of combining Chinese herbal medicine with probiotics, the research team adapted the classic formula “Er Chen Tang,” combining it with CCFM8631 and other advantageous strains to form a unique formulation, delivering tangible health benefits to users.
Looking Ahead: Joint Efforts in Three Key Areas
Mr. Ma Jun announces future collaborative research plans
Mr. Ma Jun announced the future collaborative research plan, clarifying that Infinitus will vigorously develop Chinese herbal medicine technology, focusing on the following three areas: In basic research, leveraging probiotic multi-omics and AI fermentation prediction technologies to deepen the analysis of probiotic pathways and synergistic mechanisms with Chinese herbal medicines, and to discover more proprietary strains and Chinese herbal medicine + probiotic combinations. In industrial transformation, tackling key processes such as strain cultivation, fermentation, and activity enhancement to promote industrial demonstration and bridge the gap from research and development to production. In application scenarios, targeting the gut microbiota characteristics of different populations, and focusing on areas such as immune regulation, anti-aging, metabolic management, women’s health, beauty and skincare, and oral health, to develop more high-quality, efficacy-perceivable “Chinese herbal medicine + probiotic” health products that serve public health.
Group photo
From the initial cooperation in 2016, to the official establishment of the Collaborative Innovation Research Center in 2023, and now to this upgrade in cooperation, Infinitus and Jiangnan University have continuously driven synergistic innovation research in Chinese herbal medicine + probiotics. With the full rollout of the new phase of cooperation, Infinitus will continue to invest in scientific research, deepen university-enterprise integration, and by vigorously developing Chinese herbal medicine technology, transform more scientific research achievements into high-quality health products, ensuring that science truly benefits every health-conscious user.